BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan I, Ibrar A, Abbas N. Triazolothiadiazoles and triazolothiadiazines – Biologically attractive scaffolds. European Journal of Medicinal Chemistry 2013;63:854-68. [DOI: 10.1016/j.ejmech.2013.01.060] [Cited by in Crossref: 59] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Sever B, Altıntop MD, Kuş G, Özkurt M, Özdemir A, Kaplancıklı ZA. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. European Journal of Medicinal Chemistry 2016;113:179-86. [DOI: 10.1016/j.ejmech.2016.02.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
2 Kamel MM, Megally Abdo NY. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents. European Journal of Medicinal Chemistry 2014;86:75-80. [DOI: 10.1016/j.ejmech.2014.08.047] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 6.1] [Reference Citation Analysis]
3 Rostom SA, Badr MH, Abd El Razik HA, Ashour HM. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies. European Journal of Medicinal Chemistry 2017;139:263-79. [DOI: 10.1016/j.ejmech.2017.07.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
4 Kazmi M, Khan I, Khan A, Halim SA, Saeed A, Mehsud S, Al-harrasi A, Ibrar A. Developing new hybrid scaffold for urease inhibition based on carbazole-chalcone conjugates: Synthesis, assessment of therapeutic potential and computational docking analysis. Bioorganic & Medicinal Chemistry 2019;27:115123. [DOI: 10.1016/j.bmc.2019.115123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zaib S, Khan I. Recent Advances in the Sustainable Synthesis of Quinazolines Using Earth-Abundant First Row Transition Metals. COC 2020;24:1775-92. [DOI: 10.2174/1385272824999200726230848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mohamady S, Galal M, Eldehna WM, Gutierrez DC, Ibrahim HS, Elmazar MM, Ali HI. Dual Targeting of VEGFR2 and C-Met Kinases via the Design and Synthesis of Substituted 3-(Triazolo-thiadiazin-3-yl)indolin-2-one Derivatives as Angiogenesis Inhibitors. ACS Omega 2020;5:18872-86. [PMID: 32775889 DOI: 10.1021/acsomega.0c02038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Igei M, Bakavoli M, Shiri A, Ebrahimpour Z, Azizollahi H, Beyzaei H, Moghaddam-manesh M. Synthesis of Some New Pyrimido[4,5-e]Tetrazolo[5,1-b][1,3,4]Thiadiazine Derivatives via an S–N Type Smiles Rearrangement and their Antibacterial Evaluation. Journal of Chemical Research 2016;40:628-32. [DOI: 10.3184/174751916x14742893137631] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
8 Khan I, Ibrar A, Ahmed W, Saeed A. Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue. Eur J Med Chem 2015;90:124-69. [PMID: 25461317 DOI: 10.1016/j.ejmech.2014.10.084] [Cited by in Crossref: 209] [Cited by in F6Publishing: 143] [Article Influence: 26.1] [Reference Citation Analysis]
9 Ebrahimpour Z, Shiri A, Bakavoli M, Seyedi SM, Asghari T, Mague J. Synthesis of New Pyrimido[4,5-e][1,2,4]triazolo[3,4-b][1,3,4]thiadiazine Derivatives via S/N Smiles Rearrangement: Synthesis of Pyrimidotriazolothiadiazine Derivatives. J Heterocyclic Chem 2017;54:235-41. [DOI: 10.1002/jhet.2572] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
10 Khan I, Ibrar A, Zaib S. Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges. Top Curr Chem (Cham) 2021;379:3. [PMID: 33398642 DOI: 10.1007/s41061-020-00316-4] [Reference Citation Analysis]
11 Ibrar A, Zaib S, Jabeen F, Iqbal J, Saeed A. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis: Coumarin-Triazolothiadiazine Hybrids. Arch Pharm Chem Life Sci 2016;349:553-65. [DOI: 10.1002/ardp.201500392] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
12 Afrough T, Bakavoli M, Eshghi H. Synthesis and characterisation of new 3-methyl-6-[1-(pyrimidin-4-yl)ethyl]-5 H -pyrimido[5,4- e ][1,2,4]triazolo[3,4- b ][1,3,4]thiadiazine derivatives. Journal of Chemical Research 2017;41:376-9. [DOI: 10.3184/174751917x14967701766978] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jilloju PC, Persoons L, Kurapati SK, Schols D, De Jonghe S, Daelemans D, Vedula RR. Discovery of ( ±)-3-(1H-pyrazol-1-yl)-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4] thiadiazine derivatives with promising in vitro anticoronavirus and antitumoral activity. Mol Divers 2021. [PMID: 34165689 DOI: 10.1007/s11030-021-10258-8] [Reference Citation Analysis]
14 Zaib S, Khan I. Synthetic and medicinal chemistry of phthalazines: Recent developments, opportunities and challenges. Bioorg Chem 2020;105:104425. [PMID: 33157344 DOI: 10.1016/j.bioorg.2020.104425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Kulikov AS, Epishina MA, Fershtat LL, Makhova NN. Effective synthesis of 7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines. Chem Heterocycl Comp 2018;54:669-72. [DOI: 10.1007/s10593-018-2325-8] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Khan I, Zaib S, Ibrar A. New frontiers in the transition-metal-free synthesis of heterocycles from alkynoates: an overview and current status. Org Chem Front 2020;7:3734-91. [DOI: 10.1039/d0qo00698j] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
17 Hamama WS, El-bana GG, Shaaban S, Habib OMO, Zoorob HH. An Easy Access to Construct Some Fused 1,2,4-Triazines with Ring Junction Nitrogen Systems and Their Biological Evaluation: Fused 1,2,4-Triazines with Ring Junction Nitrogen. J Heterocyclic Chem 2017;54:422-8. [DOI: 10.1002/jhet.2599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Abbas N, Zaib S, Bakht SM, Ibrar A, Khan I, Batool S, Saeed A, Iqbal J. Symmetrical aryl linked bis-iminothiazolidinones as new chemical entities for the inhibition of monoamine oxidases: Synthesis, in vitro biological evaluation and molecular modelling analysis. Bioorganic Chemistry 2017;70:17-26. [DOI: 10.1016/j.bioorg.2016.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
19 El-attar MS. Spectroscopic, thermal analysis, and nematicidal evaluation of new mixed ligand complexes of bidentate Schiff base and 1,10 phenanthroline with some transition metals. J Chin Chem Soc 2018;65:1188-98. [DOI: 10.1002/jccs.201800028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
20 Khan I, Zaib S, Ibrar A, Rama NH, Simpson J, Iqbal J. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. European Journal of Medicinal Chemistry 2014;78:167-77. [DOI: 10.1016/j.ejmech.2014.03.046] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 7.1] [Reference Citation Analysis]
21 Settypalli T, Chunduri VR, Kerru N, Nallapaneni HK, Chintha VR, Daggupati T, Yeguvapalli S, Wudayagiri R. Design, Synthesis, Neuroprotective and Antibacterial Activities of 1,2,4‐Triazolo[3,4‐b]1,3,4‐thiadiazole Linked Thieno[2,3‐d]pyrimidine Derivatives and In Silico Docking Studies. ChemistrySelect 2019;4:1627-34. [DOI: 10.1002/slct.201803917] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Mohamady S, Gibriel AA, Ahmed MS, Hendy MS, Naguib BH. Design and novel synthetic approach supported with molecular docking and biological evidence for naphthoquinone-hydrazinotriazolothiadiazine analogs as potential anticancer inhibiting topoisomerase-IIB. Bioorganic Chemistry 2020;96:103641. [DOI: 10.1016/j.bioorg.2020.103641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Bekircan O, Danış Ö, Şahin ME, Çetin M. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. Bioorg Chem 2022;118:105493. [PMID: 34814086 DOI: 10.1016/j.bioorg.2021.105493] [Reference Citation Analysis]
24 Khan I, Ibrar A, Abbas N, Saeed A. Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: Synthetic approaches and multifarious applications. European Journal of Medicinal Chemistry 2014;76:193-244. [DOI: 10.1016/j.ejmech.2014.02.005] [Cited by in Crossref: 262] [Cited by in F6Publishing: 195] [Article Influence: 32.8] [Reference Citation Analysis]
25 Aggarwal R, Sharma S, Hooda M, Sanz D, Claramunt RM, Twamley B, Rozas I. Visible-light mediated regioselective approach towards synthesis of 7-aroyl-6-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines. Tetrahedron 2019;75:130728. [DOI: 10.1016/j.tet.2019.130728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
26 Askin S, Tahtaci H, Türkeş C, Demir Y, Ece A, Akalın Çiftçi G, Beydemir Ş. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors. Bioorg Chem 2021;113:105009. [PMID: 34052739 DOI: 10.1016/j.bioorg.2021.105009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
27 Asghari T, Bakavoli M, Rahimizadeh M, Eshghi H, Saberi S, Karimian A, Hadizadeh F, Ghandadi M. Synthesis and evaluation of a new series of 3,5-bis((5-bromo-6-methyl-2-t-aminopyrimidin-4-yl)thio)-4H-1,2,4-triazol-4-amines and their cyclized products 'pyrimidinylthio pyrimidotriazolothiadiazines' as 15- lipo-oxygenase inhibitors. Chem Biol Drug Des 2015;85:216-24. [PMID: 24925519 DOI: 10.1111/cbdd.12375] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Khan I, Zaib S, Batool S, Abbas N, Ashraf Z, Iqbal J, Saeed A. Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: An update on the development of synthetic methods and pharmacological diversification. Bioorg Med Chem 2016;24:2361-81. [PMID: 27112448 DOI: 10.1016/j.bmc.2016.03.031] [Cited by in Crossref: 127] [Cited by in F6Publishing: 78] [Article Influence: 21.2] [Reference Citation Analysis]
29 Küçükgüzel ŞG, Çıkla-Süzgün P. Recent advances bioactive 1,2,4-triazole-3-thiones. Eur J Med Chem 2015;97:830-70. [PMID: 25563511 DOI: 10.1016/j.ejmech.2014.11.033] [Cited by in Crossref: 111] [Cited by in F6Publishing: 62] [Article Influence: 13.9] [Reference Citation Analysis]
30 Khan I, Ibrar A, Abbas N. Oxadiazoles as privileged motifs for promising anticancer leads: recent advances and future prospects. Arch Pharm (Weinheim) 2014;347:1-20. [PMID: 24265208 DOI: 10.1002/ardp.201300231] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
31 Sujatha K, Vedula RR. Multicomponent Efficient Synthesis of New [1,2,4]Triazolo[3,4]thiadiazines. J Heterocyclic Chem 2019;56:832-8. [DOI: 10.1002/jhet.3458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
32 Khan I, Bakht SM, Ibrar A, Abbas S, Hameed S, White JM, Rana UA, Zaib S, Shahid M, Iqbal J. Exploration of a library of triazolothiadiazole and triazolothiadiazine compounds as a highly potent and selective family of cholinesterase and monoamine oxidase inhibitors: design, synthesis, X-ray diffraction analysis and molecular docking studies. RSC Adv 2015;5:21249-67. [DOI: 10.1039/c5ra00906e] [Cited by in Crossref: 31] [Article Influence: 4.4] [Reference Citation Analysis]
33 Khan I, Panini P, Khan SU, Rana UA, Andleeb H, Chopra D, Hameed S, Simpson J. Exploiting the Role of Molecular Electrostatic Potential, Deformation Density, Topology, and Energetics in the Characterization of S···N and Cl···N Supramolecular Motifs in Crystalline Triazolothiadiazoles. Crystal Growth & Design 2016;16:1371-86. [DOI: 10.1021/acs.cgd.5b01499] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
34 Abdelrahman MH, Aboraia AS, Youssif BGM, Elsadek BEM. Design, synthesis and pharmacophoric model building of new 3-alkoxymethyl/3-phenyl indole-2-carboxamides with potential antiproliferative activity. Chem Biol Drug Des 2017;90:64-82. [DOI: 10.1111/cbdd.12928] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
35 Ismail MI, Mohamady S, Samir N, Abouzid KAM. Design, Synthesis, and Biological Evaluation of Novel 7H-[1,2,4]Triazolo[3,4-b][1,3,4]thiadiazine Inhibitors as Antitumor Agents. ACS Omega 2020;5:20170-86. [PMID: 32832771 DOI: 10.1021/acsomega.0c01829] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Khan I, Khan A, Ahsan Halim S, Saeed A, Mehsud S, Csuk R, Al-harrasi A, Ibrar A. Exploring biological efficacy of coumarin clubbed thiazolo[3,2–b][1,2,4]triazoles as efficient inhibitors of urease: A biochemical and in silico approach. International Journal of Biological Macromolecules 2020;142:345-54. [DOI: 10.1016/j.ijbiomac.2019.09.105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
37 Aytaç PS, Durmaz I, Houston DR, Çetin-atalay R, Tozkoparan B. Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins. Bioorganic & Medicinal Chemistry 2016;24:858-72. [DOI: 10.1016/j.bmc.2016.01.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
38 Ibrar A, Khan I, Abbas N. Structurally Diversified Heterocycles and Related Privileged Scaffolds as Potential Urease Inhibitors: A Brief Overview. Arch Pharm Pharm Med Chem 2013;346:423-46. [DOI: 10.1002/ardp.201300041] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
39 Milošev MZ, Jakovljević K, Joksović MD, Stanojković T, Matić IZ, Perović M, Tešić V, Kanazir S, Mladenović M, Rodić MV, Leovac VM, Trifunović S, Marković V. Mannich bases of 1,2,4-triazole-3-thione containing adamantane moiety: Synthesis, preliminary anticancer evaluation, and molecular modeling studies. Chem Biol Drug Des 2017;89:943-52. [PMID: 27933733 DOI: 10.1111/cbdd.12920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
40 Kattimani PP, Kamble RR, Dorababu A, Hunnur RK, Kamble AA, Devarajegowda H. C 5 -Alkyl-1,3,4-Oxadiazol-2-ones Undergo Dealkylation upon Nitrogen Insertion to Form 2 H -1,2,4-Triazol-3-ones: Synthesis of 1,2,4-Triazol-3-one Hybrids with Triazolothiadiazoles and Triazolothiadiazines: Synthesis of Novel 1,2,4-Triazolin-3-one Derivatives. J Heterocyclic Chem 2017;54:2258-65. [DOI: 10.1002/jhet.2813] [Cited by in Crossref: 8] [Article Influence: 1.6] [Reference Citation Analysis]
41 Ghanaat J, Khalilzadeh MA, Zareyee D. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives. Mol Divers 2021;25:223-32. [PMID: 32067134 DOI: 10.1007/s11030-020-10050-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
42 Kulikov AS, Epishina MA, Fershtat LL, Romanova AA, Makhova NN. Effective synthesis of 6-substituted 7H-tetrazolo[5,1-b][1,3,4]thiadiazines via a one-pot condensation/nitrosation/azide-tetrazole tautomerism reaction sequence. Tetrahedron Letters 2017;58:3998-4002. [DOI: 10.1016/j.tetlet.2017.09.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
43 Rode ND, Sonawane AD, Garud DR, Joshi RR, Joshi RA, Likhite AP. First regioselective iodocyclization reaction of 3-aryl-5-(prop-2-ynylthio)-1H-1,2,4-triazoles. Tetrahedron Letters 2015;56:5140-4. [DOI: 10.1016/j.tetlet.2015.07.006] [Cited by in Crossref: 10] [Article Influence: 1.4] [Reference Citation Analysis]
44 Aouad MR, Al-saedi AMH, Ali AA, Rezki N, Messali M. Preparation of Novel 3-Fluorophenyl Triazolothiadiazoles and of Triazolothiadiazines. Organic Preparations and Procedures International 2016;48:355-70. [DOI: 10.1080/00304948.2016.1194134] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
45 Salem ME, Darweesh AF, Elwahy AHM. Synthesis of novel scaffolds based on thiazole or triazolothiadiazine linked to benzofuran or benzo[ d ]thiazole moieties as new hybrid molecules. Synthetic Communications 2020;50:256-70. [DOI: 10.1080/00397911.2019.1694689] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
46 Martins P, Jesus J, Santos S, Raposo LR, Roma-Rodrigues C, Baptista PV, Fernandes AR. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box. Molecules 2015;20:16852-91. [PMID: 26389876 DOI: 10.3390/molecules200916852] [Cited by in Crossref: 230] [Cited by in F6Publishing: 143] [Article Influence: 32.9] [Reference Citation Analysis]
47 Le Meur M, Bourg S, Massip S, Marchivie M, Jarry C, Guillaumet G, Routier S. First Palladium-Catalyzed Direct Regioselective C-5 (Het)Arylation of Mono- or Disubstituted Thiazolo[3,2- b ][1,2,4]triazoles: C-5 (Het)Arylation of Substituted Thiazolo[3,2- b ][1,2,4]triazoles. Eur J Org Chem 2014;2014:3704-14. [DOI: 10.1002/ejoc.201402193] [Cited by in Crossref: 15] [Article Influence: 1.9] [Reference Citation Analysis]